CBD stability boost for Avecho ahead of insomnia clinical trial by Steve Jones June 23, 2023June 23, 2023 Avecho Biotechnology’s soft-gel capsule showed no significant changes after two years at room temperature with barely […]
Avecho turns to new investors to raise funds for CBD clinical trial by Steve Jones May 9, 2023May 9, 2023
Bod strikes CBD over-the-counter deal with pharma firm Arrotex by Steve Jones December 2, 2022December 2, 2022
Cann Global boss: ‘launch of hard-pill format will lift barriers for wary GPs and patients’ by Steve Jones October 28, 2021December 22, 2021
A year of frustration but Cann Group vows to deliver for shareholders and consumers by Steve Jones August 12, 2021August 17, 2021
Patience the watchword as companies line up to put S3 visions to the test by Steve Jones March 30, 2021April 1, 2021
Black market CBD remains a huge problem in Australia by Josie Tutty November 4, 2020November 11, 2020
Medical experts defer decision to subsidise CBD epilepsy treatment by Steve Jones August 24, 2020August 24, 2020